Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02567656 |
| Title | Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Rhizen Pharmaceuticals SA |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | United States | Details | |
| Chao Family Comprehensive Cancer Center University of California Irvine | Orange | California | 92868 | United States | Details | |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | United States | Details | |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | United States | Details | |
| University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109-0944 | United States | Details | |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106-5028 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |